1-2 of 2
Kai Grosch
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Efficacy, Safety, and Biomarker Analysis of 5 Mg and 7.5 Mg Doses of Crizanlizumab in Patients with Sickle Cell Disease: Primary Analyses from the Phase III STAND Study

Miguel R Abboud, Rodolfo D Cançado, Mariane De Montalembert, Wally R Smith, Hala Rimawi, Ersi Voskaridou, Birol Guvenc, Deborah Keefe, Kai Grosch, Michele L Nassin, Jimmy Watson, Justin Yssel, Evgeniya Reshetnyak, Yvonne Dei Adomakoh
Journal: Blood
Blood (2023) 142 (Supplement 1): 272.
https://doi.org/10.1182/blood-2023-185429
Published: 2023
Journal Articles

A Phase I Study of Midostaurin (PKC412) Investigating Cardiac Interval Effects In Healthy Subjects

Adam del Corral, Catherine Dutreix, Alice Huntsman Labed, Sumita Rai, Kai Grosch, Joel Morganroth, Robert Harrell, Jr., Yanfeng Wang
Journal: Blood
Blood (2010) 116 (21): 4362.
https://doi.org/10.1182/blood.V116.21.4362.4362
Published: 2010